Lifeboat Foundation

In partnership with NASA, the Lockheed Martin Skunk Works team is solving one of the most persistent challenges of supersonic flight – the sonic boom. NASA awarded Lockheed Martin Skunk Works a contract in February 2016 for the preliminary design of X-59, designed to reduce a sonic boom to a gentle thump.

In 2018, Lockheed Martin Skunk Works was selected for the design, build and flight test of the Low-Boom Flight Demonstrator (LBFD). The X-59 aircraft will collect community response data on the acceptability of the quiet sonic boom generated by our design, helping NASA establish an acceptable commercial supersonic noise standard to overturn current regulations banning supersonic travel over land. This would open the door to an entirely new global market for aircraft manufacturers, enabling passengers to travel anywhere in the world in half the time it takes today.

Continue reading “X-59 QueSST” »

This new household appliance turns it into energy.

• https://twitter.com/share?url=https://www.fastcompany.com/30…0Resource” rel=“noopener noreferrer”>

2 minute Read.

Morad said in its infancy, AEBi was essentially “doing what everyone else was doing, trying to discover individual novel peptides for specific cancers.”

But then Morad and his colleague, Dr. Hanan Itzhaki, began attempting to identify why other cancer-killing drugs and treatments didn’t work or eventually failed. And they say they’ve found a way to counter that effect.

Morad said most anti-cancer drugs attack a specific target on or in the cancer cell. “Inhibiting the target usually affects a physiological pathway that promotes cancer. Mutations in the targets – or downstream in their physiological pathways – could make the targets not relevant to the cancer nature of the cell, and hence the drug attacking it is rendered ineffective,” he told The Jerusalem Post.

Continue reading “Israeli Scientists Claim They’re On The Path To A Cure For Cancer” »

(Advances in science and public health are increasing longevity and enhancing the quality of life for people around the world. In this series of interviews with the Milken Institute Center for the Future of Aging, 14 visionaries are revealing exciting trends and insights regarding healthy longevity, sharing their vision for a better future. The Longevity Innovators interviews highlight new discoveries in biomedical and psychosocial science, as well as strategies to promote prevention and wellness for older adults. This is the last story in the series.)

Director of the Longevity Genes Project at the Albert Einstein College of Medicine, Dr. Nir Barzilai has discovered several longevity genes in humans that appear to protect centenarians against major age-related diseases. Barzilai is also co-founder of CohBar, a biotech company developing mitochondria-based therapeutics to treat diseases associated with aging. In an interview with the Milken Institute Center for the Future of Aging, Barzilai explains why some people have longevity genes and the challenges in drug design for age-related diseases:

An international team of researchers led by University of Wisconsin-Madison scientists has developed an easily implantable weight-loss device. In lab experiments, the device helped rats shed 38% of their body weight.

The most deadly aspect of breast cancer is metastasis, cancer cells spreading throughout the body. Researchers at the University and the University Hospital of Basel have now discovered a substance that suppresses the formation of metastases. In the journal Cell, the team of molecular biologists, co…

Celebrate Bedford Day, a celebration of the first human to be placed into cryonic suspension.

Dr. James Bedford is the oldest person currently in Cryostasis.

Continue reading “Bedford Day Celebration with Ben Best” »

Conference at ludwig maximilian university in munich.

Researchers have developed new bioinspired material that interacts with surrounding tissues to promote healing.